Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.2B | 1.3B | 1.2B | 1.3B |
Cost of revenue | 991M | 981M | 971M | 1.0B |
Gross profit | 252M | 273M | 274M | 309M |
Operating expense | ||||
Research & development | -4M | 10M | 9M | 8M |
Selling general and admin | 105M | 108M | 106M | 101M |
Other operating expenses | 4M | 30M | 28M | 22M |
Operating income | 147M | 125M | 131M | 178M |
Non operating interest income | ||||
Income | 3M | 12M | 4M | 5M |
Expense | 35M | 25M | 35M | 40M |
Other income expense | — | — | — | — |
Pretax income | 115M | 41M | 29M | 115M |
Tax provision | 32M | 8M | 11M | 41M |
Net income | 83M | 33M | 18M | 73M |
Basic EPS | 0.8 | 0.3 | 0.2 | 0.6 |
Diluted EPS | 0.8 | 0.3 | 0.2 | 0.6 |
Basic average shares | 104.5M | 104.5M | 104.1M | 105.5M |
Diluted average shares | 105.6M | 105.5M | 105.2M | 106.6M |
EBITDA | 244M | 237M | 232M | 289M |
Net income from continuing op. | 83M | 33M | 18M | 73M |
Minority interests | -2M | -3M | 1M | -6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |